US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adicet Bio, Inc.

0.6690

0.0000

Volume:190.35K

Turnover:126.65K

Market Cap:55.33M

PE:-0.52

High:0.6761

Open:0.6750

Low:0.6600

Close:0.6690

Loading ...

Overview Company News Filings

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Adicet Announces Poster Presentations Highlighting Adi-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting

THOMSON REUTERS

Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting

Adicet Bio shares rise on FDA Fast Track Designation for ADI-001

Adicet Bio Receives FDA Fast Track Designation for Adi-001 for the Treatment of Systemic Sclerosis (Ssc)

THOMSON REUTERS

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)

H.C. Wainwright Sticks to Its Hold Rating for Adicet Bio (ACET)

Adicet Bio Receives FDA Fast Track Designation for Adi-001 for the Treatment of Refractory Systemic Lupus Erythematosus (Sle) With Extrarenal Involvement

THOMSON REUTERS

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement

Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

BRIEF-Adicet Bio Provides Corporate Update

Adicet Bio Inc - Patient Enrollment for Sle, Ssc, Iim, SPS Expected in 1Q25

THOMSON REUTERS

Adicet Bio Inc - Preliminary Data for Adi-001 in Ln Expected in 1H25

THOMSON REUTERS

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

THOMSON REUTERS

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACET/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACET","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACET\",,,,,undefined,":{"symbol":"ACET","market":"US","secType":"STK","nameCN":"Adicet Bio, Inc.","latestPrice":0.669,"timestamp":1750438652666,"preClose":0.669,"halted":0,"volume":190347,"delay":0,"floatShares":61372286,"shares":82709625,"eps":-1.291126,"marketStatus":"Trading","change":0,"latestTime":"06-20 12:57:35 EDT","open":0.675,"high":0.6761,"low":0.66,"amount":126653.86728270001,"amplitude":0.024066,"askPrice":0.669,"askSize":500,"bidPrice":0.6669,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-1.291126,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750449600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1516942800000,"exchange":"NASDAQ","adjPreClose":0.669,"dividendRate":0.001495,"preHourTrading":{"tag":"盘前","latestPrice":0.668,"preClose":0.669,"latestTime":"09:25 EDT","volume":107,"amount":73.12199919000001,"timestamp":1750425900162},"postHourTrading":{"tag":"盘后","latestPrice":0.6653,"preClose":0.669,"latestTime":"19:12 EDT","volume":316,"amount":210.2876,"timestamp":1750288332441},"volumeRatio":1.122369,"impliedVol":1.5718,"impliedVolPercentile":0.724},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACET\",,,,,undefined,":{"symbol":"ACET","floatShares":61372286,"roa":"-32.68%","roe":"-55.83%","lyrEps":-1.332954,"volumeRatio":1.122369,"shares":82709625,"dividePrice":0.001,"high":0.6761,"amplitude":0.024066,"preClose":0.669,"low":0.66,"week52Low":0.4471,"pbRate":"0.34","week52High":1.7,"institutionHeld":0.7488,"latestPrice":0.669,"committee":-0.111111,"eps":-1.291126,"divideRate":0.001495,"volume":190347,"delay":0,"ttmEps":-1.291126,"open":0.675,"prevYearClose":0.962,"prevWeekClose":0.7503,"prevMonthClose":0.7183,"prevQuarterClose":0.755,"fiveDayClose":0.7799,"twentyDayClose":0.7,"sixtyDayClose":0.885},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACET\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517911392","title":"Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2517911392","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517911392?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:01","pubTimestamp":1741294860,"startTime":"0","endTime":"0","summary":"Phase 1 clinical trial of ADI-001 in autoimmune diseases ongoing; on track to report preliminary clinical data from lupus nephritis  patient cohort in 1H25. Additional LN clinical data and preliminary clinical data from other autoimmune patient cohorts anticipated in 2H25. Initiation of ADI-001 Phase 1 clinical trial patient enrollment in systemic lupus erythematosus , systemic sclerosis , idiopathic inflammatory myopathy  and stiff person syndrome  expected in 2Q25; anti-neutrophil cytoplasmic autoantibody  associated vasculitis  patient enrollment expected to be initiated in 2H25. Continuing to advance phase 1 trial of ADI-001 in autoimmune diseases. In November 2024, Adicet announced the dosing of the first patient in the Phase 1 trial evaluating ADI-001 in LN. Enrollment for SLE, SSc, IIM, and SPS patients is expected to commence in the second quarter of 2025, with the initiation of AAV patient enrollment anti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-reports-fourth-quarter-210100654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","BK4230","SITC","CAR","BK4022","BK4080","BK4139","IIM","LU2065732104.USD","ACR","SLE","ACET","BK4110","BK4231","PRGS","BK4077"],"gpt_icon":0},{"id":"2516468753","title":"Adicet Announces Poster Presentations Highlighting Adi-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2516468753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516468753?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUARHSWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2516389376","title":"Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2516389376","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516389376?lang=en_us&edition=fundamental","pubTime":"2025-03-03 20:00","pubTimestamp":1741003200,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, March 03, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Cancer  2025 Spring Scientific Meeting taking place March 12-14, 2025, in San Diego, C.A.Details of the poster presentation are as follows:. Abstract Title: A Phase 1/2 First in Human Study of ADI-270, an Armored Allogeneic Anti-CD70 Chimeric Antigen Receptor γδ T Cell Therapy, in Relapsed or Refractory (R/R) Clear Cell Renal Cell Carcinoma Poster/Abstract Number: 136Presenting Author: Gregory Vosganian, M.D.Date/Time: Thursday, March 13, 2025, from 5:00 p.m. – 6:30 p.m. PT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-announces-poster-presentations-highlighting-120000270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0124384867.USD","LU1978683503.SGD","LU0444971666.USD","LU1992135472.HKD","LU0082616367.USD","LU0724618433.USD","BK4588","LU1815336760.USD","LU2237438978.USD","LU1670710588.SGD","LU1074936037.SGD","LU1670710661.SGD","LU1861219969.SGD","BK4605","LU2458330243.SGD","LU0314104364.USD","IE00B5949003.HKD","LU1670711040.USD","LU2237443549.SGD","SITC","LU0957808578.USD","LU2298322129.HKD","BK4585","BK4231","LU2237443978.SGD","IE00BZ199S13.USD","LU1670711123.USD","LU2272731782.SGD","ACET","LU1244550494.USD","IE0009356076.USD","LU1803068979.SGD","ADI","LU2237443382.USD","LU1861214812.USD","LU1244550221.USD","LU0109392836.USD","LU1992135399.USD","LU1244550577.SGD","LU2237443622.USD","BK4141","LU2360107325.USD","LU0719512351.SGD","BK4080","LU1642822529.SGD","BK4512","LU2272731600.USD","BK4515","BK4139"],"gpt_icon":0},{"id":"2514880016","title":"Adicet Bio shares rise on FDA Fast Track Designation for ADI-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2514880016","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514880016?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:36","pubTimestamp":1740663388,"startTime":"0","endTime":"0","summary":"Investing.com --Adicet Bio shares jumped 6.4% premarket after the company announced that the U.S. Food and Drug Administration  granted Fast Track Designation to its investigational therapy ADI-001 for the treatment of systemic sclerosis .ADI-001 is a CAR T cell therapy that targets CD20 to treat autoimmune diseases.Fast Track Designation is intended to accelerate the development and regulatory review of drugs aimed at treating serious conditions with unmet medical needs.The designation provides Adicet Bio with several potential advantages, including more frequent FDA interactions, eligibility for priority review, and the possibility of accelerated approval if clinical data supports it.This milestone strengthens Adicet Bio’s position in the cell therapy space, particularly in autoimmune diseases and cancer, where the company is focused on developing novel gamma delta T cell-based treatments.The stock’s premarket jump reflects investor optimism about the regulatory progress of ADI-001 a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-shares-rise-fda-133628680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","LU1084165304.USD","LU1670627923.USD","BK4581","LU0072461881.USD","LU2237443549.SGD","LU1582986359.USD","LU0061474960.USD","IE00B3S45H60.SGD","LU1301847155.USD","LU2236285917.USD","LU2237443382.USD","LU2362540622.SGD","FAST","LU0820561818.USD","LU2108987350.USD","ADI","BK4504","LU1992135472.HKD","LU2237957902.USD","IE000ITXATA3.USD","LU1366333091.USD","LU0127658192.USD","LU2247934214.USD","LU1267930813.SGD","IE00B19Z9505.USD","LU0029864427.USD","LU1221951046.USD","LU2491050154.USD","LU0683600562.USD","LU0868494617.USD","LU1988902786.USD","ACET","LU2458330169.SGD","IE00BFSS7M15.SGD","LU0310800379.SGD","LU0302445910.USD","LU1116320737.USD","LU0187121727.USD","LU0353189680.USD","LU1043141396.HKD","LU2111349929.HKD","LU2264538146.SGD","LU2023250504.SGD","IE0004086264.USD","LU0128525929.USD","LU0095938881.EUR","LU2413666426.HKD","LU2361044865.SGD"],"gpt_icon":1},{"id":"2514032138","title":"Adicet Bio Receives FDA Fast Track Designation for Adi-001 for the Treatment of Systemic Sclerosis (Ssc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514032138","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514032138?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657612,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI0X5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2514806912","title":"Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514806912","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514806912?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, February 27, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration  has granted Fast Track Designation to ADI-001 for the potential treatment of adult patients with systemic sclerosis .Fast Track Designation is a process designed to facilitate development and expedite the review of drugs intended to treat serious conditions and fill an unmet medical need.This press release contains \"forward-looking statements\" of Adicet within the meaning of the Private Securities Litigation Reform Act of 1995 relating to the business and operations of Adicet. The words \"anticipate,\" \"believe,\" \"continue,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\" \"plan,\" \"potential,\" \"predict,\" \"project,\" \"should,\" \"target,\" \"would\" and similar expressions are intended to identify forward-looking statements, althoug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-receives-fda-fast-120000634.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861219969.SGD","IE00BZ199S13.USD","LU2237438978.USD","LU1670711040.USD","LU1244550494.USD","BK4077","LU2237443549.SGD","ADI","LU2237443622.USD","LU1670710588.SGD","LU0124384867.USD","LU1815336760.USD","LU1074936037.SGD","IE00BD6J9T35.USD","LU0889565833.HKD","LU1642822529.SGD","ACET","LU1992135472.HKD","BK4139","LU1670710661.SGD","IE00B5949003.HKD","BK4141","BK4512","LU0724618433.USD","LU2458330243.SGD","LU0444971666.USD","LU0314104364.USD","CAR","LU2458330169.SGD","BK4605","BK4230","BK4561","LU1861214812.USD","LU2237443978.SGD","LU1992135399.USD","FAST","LU0719512351.SGD","IE0009356076.USD","SLE","LU1244550221.USD","LU0109392836.USD","BK4515","LU1978683503.SGD","LU2272731782.SGD","LU2237443382.USD","LU2272731600.USD","LU0082616367.USD","LU1244550577.SGD","LU2298322129.HKD","LU1803068979.SGD"],"gpt_icon":0},{"id":"2509872280","title":"H.C. Wainwright Sticks to Its Hold Rating for Adicet Bio (ACET)","url":"https://stock-news.laohu8.com/highlight/detail?id=2509872280","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509872280?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:55","pubTimestamp":1738767314,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Edward White reiterated a Hold rating on Adicet Bio (ACET – Research Report) today. The company’s shares opened today at $1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-hold-rating-for-adicet-bio-acet-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-hold-rating-for-adicet-bio-acet-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACET"],"gpt_icon":0},{"id":"2509407348","title":"Adicet Bio Receives FDA Fast Track Designation for Adi-001 for the Treatment of Refractory Systemic Lupus Erythematosus (Sle) With Extrarenal Involvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2509407348","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509407348?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:10","pubTimestamp":1738757414,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW197:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2509407237","title":"Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement","url":"https://stock-news.laohu8.com/highlight/detail?id=2509407237","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509407237?lang=en_us&edition=fundamental","pubTime":"2025-02-05 20:10","pubTimestamp":1738757400,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, February 05, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration  has granted Fast Track Designation to ADI-001 for the potential treatment of adult patients with refractory systemic lupus erythematosus  with extrarenal involvement.Fast Track Designation is a process designed to facilitate development and expedite the review of drugs intended to treat serious conditions and fill an unmet medical need.This press release contains \"forward-looking statements\" of Adicet within the meaning of the Private Securities Litigation Reform Act of 1995 relating to the business and operations of Adicet. The words \"anticipate,\" \"believe,\" \"continue,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\" \"plan,\" \"potential,\" \"predict,\" \"project,\" \"should,\" \"target,\" \"would\" and similar expressions are intende","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-receives-fda-fast-121000035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1670711123.USD","LU2237443622.USD","IE00BD6J9T35.USD","LU1992135472.HKD","BK4141","LU1074936037.SGD","LU1670711040.USD","LU0889565833.HKD","LU2298322129.HKD","CAR","BK4515","LU2237438978.USD","LU1244550577.SGD","ADI","LU1642822529.SGD","LU1670710661.SGD","LU0314104364.USD","LU0719512351.SGD","LU2237443978.SGD","LU0124384867.USD","LU1861214812.USD","ACET","BK4605","LU2458330243.SGD","LU1815336760.USD","LU1978683503.SGD","IE00B5949003.HKD","BK4077","BK4585","LU2237443549.SGD","BK4230","LU0444971666.USD","LU1861219969.SGD","IE00BZ199S13.USD","BK4512","LU1992135399.USD","FAST","SLE","LU2272731600.USD","BK4139","LU2272731782.SGD","LU1244550221.USD","LU2458330169.SGD","LU0082616367.USD","IE0009356076.USD","LU1670710588.SGD","LU0724618433.USD","BK4588","LU2237443382.USD","LU0109392836.USD"],"gpt_icon":0},{"id":"2508146915","title":"Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508146915","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508146915?lang=en_us&edition=fundamental","pubTime":"2025-02-01 07:06","pubTimestamp":1738364760,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nTUA9BNSDV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2508891504","title":"Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508891504","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508891504?lang=en_us&edition=fundamental","pubTime":"2025-02-01 07:06","pubTimestamp":1738364760,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, January 31, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on January 31, 2025.All of the above-described awards were granted outside of Adicet’s stockholder-approved equity incentive plans pursuant to Adicet’s 2022 Inducement Plan , which was adopted by the board of directors in January 2022 and subsequently amended in January 2023. The awards were authorized by a majority of Adicet’s independent directors or the compensation committee of the board of directors, which is comprised solely of independent directors, as a material inducement to the employees entering into employment with Adicet in accordance with Nasdaq Listing Rule 5635.Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cance","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-reports-inducement-grants-230600745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4112","BK4585",".IXIC","IE00BKPKM429.USD","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD","ACET","BK4588","BK4139"],"gpt_icon":0},{"id":"2507687414","title":"Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507687414","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507687414?lang=en_us&edition=fundamental","pubTime":"2025-01-29 20:00","pubTimestamp":1738152000,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, January 29, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference being held from February 5-6, 2025 in New York.Details of the event are as follows:Date: Wednesday, February 5, 2025Time: 2:00 p.m. ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-participate-fireside-chat-120000750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","SMID","ACET","BK4011"],"gpt_icon":0},{"id":"2502083138","title":"BRIEF-Adicet Bio Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083138?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:16","pubTimestamp":1736371016,"startTime":"0","endTime":"0","summary":"BRIEF-Adicet Bio Provides Corporate Update Jan 8 (Reuters) - Adicet Bio Inc ACET.O:ADICET BIO PROVIDES CORPORATE UPDATE AND HIGHLIGHTS EXPECTED 2025 MILESTONESADICET BIO INC - PRELIMINARY DATA FOR ADI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAB58CWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2502083595","title":"Adicet Bio Inc - Patient Enrollment for Sle, Ssc, Iim, SPS Expected in 1Q25","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083595?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:10","pubTimestamp":1736370600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAB58CWM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2502083591","title":"Adicet Bio Inc - Preliminary Data for Adi-001 in Ln Expected in 1H25","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083591","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083591?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:10","pubTimestamp":1736370600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAB58CWM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2502083531","title":"Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2502083531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502083531?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:10","pubTimestamp":1736370600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAB58CWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2502085244","title":"Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2502085244","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502085244?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:10","pubTimestamp":1736370600,"startTime":"0","endTime":"0","summary":"Adicet made significant progress in 2024 and is well-positioned for success in 2025: Advancing Phase 1 clinical trial evaluating ADI-001 across six autoimmune diseases; preliminary data in lupus nephritis  patients anticipated in 1H25, data from other patient cohorts expected in 2H25. Patient enrollment in systemic lupus erythematosus , systemic sclerosis , idiopathic inflammatory myopathy  and stiff person syndrome  expected to be initiated in 1Q25; initiation of patient enrollment in anti-neutrophil cytoplasmic autoantibody  associated vasculitis  expected in 2H25. REDWOOD CITY, Calif. & BOSTON, January 08, 2025----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate updates and highlighted upcoming milestones for 2025.In September 2024, Adicet presented clinical biomarker data from the Phase 1 GLEAN trial of ADI-001 at the 9th Annual CAR-TCR Summit dem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-provides-corporate-highlights-211000326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACET","SLE","IIM","BK4139","CAR","BK4077","BK4022","BK4230"],"gpt_icon":0},{"id":"2500298726","title":"BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500298726","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500298726?lang=en_us&edition=fundamental","pubTime":"2025-01-01 06:52","pubTimestamp":1735685565,"startTime":"0","endTime":"0","summary":"BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)Adicet Bio Inc ACET.O:ADICET BIO REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nBw4NKnnLaFurther company coverage: ACET.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nTUA1RCZXF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","BK4588","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4112","BK4139","ACET","BK4585","LU2210149790.SGD"],"gpt_icon":0},{"id":"2500623313","title":"Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500623313","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500623313?lang=en_us&edition=fundamental","pubTime":"2025-01-01 05:48","pubTimestamp":1735681680,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nTUA1RCZXF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2095319765.USD","BK4585","LU2210149790.SGD","LU2210150020.SGD","BK4112","BK4139","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588","ACET","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2500625479","title":"Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500625479","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500625479?lang=en_us&edition=fundamental","pubTime":"2025-01-01 05:48","pubTimestamp":1735681680,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, December 31, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on December 31, 2024.The above-described award was granted outside of Adicet’s stockholder-approved equity incentive plans pursuant to Adicet’s 2022 Inducement Plan , which was adopted by the board of directors in January 2022 and subsequently amended in January 2023. The award was authorized by the compensation committee of the board of directors, which is comprised solely of independent directors, as a material inducement to the employee entering into employment with Adicet in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-reports-inducement-grant-214800519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64PRP62.GBP","BK4112",".IXIC","ACET","BK4139","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2095319765.USD","BK4585","LU2210150020.SGD","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACET\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"ACET","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-03-06","symbol":"ACET","fiscalQuarterEnding":"2024/12","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2024-11-06","symbol":"ACET","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-08-13","symbol":"ACET","fiscalQuarterEnding":"2024/06","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-05-14","symbol":"ACET","fiscalQuarterEnding":"2024/03","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACET\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACET\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.375,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1727755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACET\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACET","date":"2025-06-18","current":-0.473966,"percent":0.94863,"low":-20.788688,"twenty":-11.017899,"median":-4.500542,"eighty":-0.726139,"high":-0.315643,"avg":-5.640115,"sd":5.149435,"marketCap":55605680},"quantilePoints":[{"date":"2020-09-18","current":-12.223294,"twenty":-11.014673,"median":-9.201742,"eighty":-8.958418,"marketCap":419222319},{"date":"2020-09-25","current":-6.328696,"twenty":-9.039526,"median":-7.068377,"eighty":-6.14706,"marketCap":217055294},{"date":"2020-10-02","current":-6.791354,"twenty":-8.357534,"median":-6.791354,"eighty":-6.153914,"marketCap":232923054},{"date":"2020-10-09","current":-7.836617,"twenty":-7.781783,"median":-6.965564,"eighty":-6.372106,"marketCap":268772440},{"date":"2020-10-16","current":-7.72238,"twenty":-7.822909,"median":-7.21974,"eighty":-6.578874,"marketCap":264854474},{"date":"2020-10-23","current":-7.134063,"twenty":-7.77036,"median":-7.288282,"eighty":-6.791354,"marketCap":244676951},{"date":"2020-10-30","current":-6.123071,"twenty":-7.720095,"median":-7.15691,"eighty":-6.52861,"marketCap":210002956},{"date":"2020-11-06","current":-6.806308,"twenty":-7.709814,"median":-6.991267,"eighty":-6.430367,"marketCap":233442752},{"date":"2020-11-13","current":-7.600663,"twenty":-7.669831,"median":-6.996979,"eighty":-6.430367,"marketCap":260687541},{"date":"2020-11-20","current":-7.314924,"twenty":-7.615433,"median":-7.074903,"eighty":-6.437221,"marketCap":250887257},{"date":"2020-11-27","current":-7.103477,"twenty":-7.598377,"median":-7.117764,"eighty":-6.482916,"marketCap":243635047},{"date":"2020-12-04","current":-7.863543,"twenty":-7.620356,"median":-7.103477,"eighty":-6.690826,"marketCap":269703801},{"date":"2020-12-11","current":-7.177769,"twenty":-7.620356,"median":-7.145487,"eighty":-6.791354,"marketCap":246183121},{"date":"2020-12-18","current":-8.275008,"twenty":-7.647524,"median":-7.177769,"eighty":-6.794345,"marketCap":283816210},{"date":"2020-12-24","current":-8.200715,"twenty":-7.72238,"median":-7.206343,"eighty":-6.806308,"marketCap":281268136},{"date":"2020-12-31","current":-8.029272,"twenty":-7.842002,"median":-7.231164,"eighty":-6.81088,"marketCap":275387966},{"date":"2021-01-08","current":-7.840684,"twenty":-7.880687,"median":-7.274921,"eighty":-6.83031,"marketCap":268919779},{"date":"2021-01-15","current":-7.486367,"twenty":-7.864686,"median":-7.354927,"eighty":-6.841184,"marketCap":256767427},{"date":"2021-01-22","current":-8.309296,"twenty":-7.958409,"median":-7.448213,"eighty":-6.851749,"marketCap":284992244},{"date":"2021-01-29","current":-7.029185,"twenty":-7.965266,"median":-7.450146,"eighty":-6.865888,"marketCap":241086974},{"date":"2021-02-05","current":-7.240632,"twenty":-7.953837,"median":-7.354927,"eighty":-6.880317,"marketCap":248339183},{"date":"2021-02-12","current":-14.744768,"twenty":-7.988752,"median":-7.450146,"eighty":-6.910317,"marketCap":505716040},{"date":"2021-02-19","current":-14.71987,"twenty":-8.032701,"median":-7.472996,"eighty":-6.929451,"marketCap":504862118},{"date":"2021-02-26","current":-13.980224,"twenty":-8.198429,"median":-7.528178,"eighty":-6.940161,"marketCap":479493736},{"date":"2021-03-05","current":-12.510064,"twenty":-8.300152,"median":-7.586376,"eighty":-6.958322,"marketCap":429070163},{"date":"2021-03-12","current":-12.789081,"twenty":-8.654016,"median":-7.625279,"eighty":-6.977444,"marketCap":469077921},{"date":"2021-03-19","current":-12.606418,"twenty":-12.160165,"median":-7.660668,"eighty":-6.990125,"marketCap":462378194},{"date":"2021-03-26","current":-11.392595,"twenty":-12.364733,"median":-7.699533,"eighty":-6.998432,"marketCap":417857597},{"date":"2021-04-01","current":-11.366584,"twenty":-12.191729,"median":-7.716668,"eighty":-7.00404,"marketCap":416903584},{"date":"2021-04-09","current":-11.435946,"twenty":-12.010661,"median":-7.732957,"eighty":-7.020041,"marketCap":419447618},{"date":"2021-04-16","current":-10.61228,"twenty":-11.720327,"median":-7.806395,"eighty":-7.032614,"marketCap":389237214},{"date":"2021-04-23","current":-12.302962,"twenty":-11.720327,"median":-7.83865,"eighty":-7.050901,"marketCap":451248044},{"date":"2021-04-30","current":-13.811571,"twenty":-12.427812,"median":-7.869258,"eighty":-7.07376,"marketCap":506580786},{"date":"2021-05-07","current":-12.346313,"twenty":-12.499856,"median":-7.966409,"eighty":-7.094333,"marketCap":452838066},{"date":"2021-05-14","current":-11.636081,"twenty":-12.436483,"median":-7.996548,"eighty":-7.109192,"marketCap":426788194},{"date":"2021-05-21","current":-8.596808,"twenty":-12.339377,"median":-8.0207,"eighty":-7.132453,"marketCap":460023817},{"date":"2021-05-28","current":-7.978504,"twenty":-12.309898,"median":-8.029272,"eighty":-7.138632,"marketCap":426937733},{"date":"2021-06-04","current":-7.294802,"twenty":-12.302962,"median":-7.996548,"eighty":-7.15691,"marketCap":390352160},{"date":"2021-06-11","current":-6.98565,"twenty":-12.223294,"median":-7.975314,"eighty":-7.132051,"marketCap":373809118},{"date":"2021-06-18","current":-6.266277,"twenty":-12.065471,"median":-7.949265,"eighty":-7.069188,"marketCap":335314732},{"date":"2021-06-25","current":-5.766877,"twenty":-11.817433,"median":-7.852113,"eighty":-7.000611,"marketCap":308591357},{"date":"2021-07-02","current":-5.903617,"twenty":-11.791422,"median":-7.835818,"eighty":-6.985555,"marketCap":315908472},{"date":"2021-07-09","current":-5.499341,"twenty":-11.667149,"median":-7.806395,"eighty":-6.932583,"marketCap":294275263},{"date":"2021-07-16","current":-4.637283,"twenty":-11.621631,"median":-7.77184,"eighty":-6.854786,"marketCap":248145627},{"date":"2021-07-23","current":-4.833475,"twenty":-11.479297,"median":-7.720674,"eighty":-6.81088,"marketCap":258644096},{"date":"2021-07-30","current":-4.399473,"twenty":-11.43768,"median":-7.704389,"eighty":-6.63694,"marketCap":235420210},{"date":"2021-08-06","current":-4.155719,"twenty":-11.435946,"median":-7.66924,"eighty":-6.406377,"marketCap":222376658},{"date":"2021-08-13","current":-4.402445,"twenty":-11.401265,"median":-7.627258,"eighty":-6.225849,"marketCap":246140692},{"date":"2021-08-20","current":-3.941128,"twenty":-11.371786,"median":-7.589233,"eighty":-6.116457,"marketCap":220348459},{"date":"2021-08-27","current":-4.596084,"twenty":-11.366584,"median":-7.547276,"eighty":-6.002308,"marketCap":256967062},{"date":"2021-09-03","current":-4.533436,"twenty":-11.345776,"median":-7.482484,"eighty":-5.806364,"marketCap":253464413},{"date":"2021-09-10","current":-4.334102,"twenty":-11.309361,"median":-7.452079,"eighty":-5.73834,"marketCap":242319621},{"date":"2021-09-17","current":-4.0949,"twenty":-11.288553,"median":-7.415748,"eighty":-5.46367,"marketCap":228945870},{"date":"2021-09-24","current":-4.328406,"twenty":-11.283351,"median":-7.354927,"eighty":-5.029668,"marketCap":242001198},{"date":"2021-10-01","current":-4.630256,"twenty":-11.274681,"median":-7.307836,"eighty":-4.803749,"marketCap":258877598},{"date":"2021-10-08","current":-4.197415,"twenty":-11.250823,"median":-7.276966,"eighty":-4.755552,"marketCap":234677478},{"date":"2021-10-15","current":-4.578998,"twenty":-11.231609,"median":-7.234917,"eighty":-4.643318,"marketCap":256011794},{"date":"2021-10-22","current":-4.61317,"twenty":-11.191447,"median":-7.21974,"eighty":-4.634472,"marketCap":257922330},{"date":"2021-10-29","current":-4.897933,"twenty":-11.161969,"median":-7.180626,"eighty":-4.634472,"marketCap":273843461},{"date":"2021-11-05","current":-5.23965,"twenty":-11.142894,"median":-7.166339,"eighty":-4.643318,"marketCap":292948819},{"date":"2021-11-12","current":-5.650037,"twenty":-11.101277,"median":-7.134172,"eighty":-4.661011,"marketCap":311565637},{"date":"2021-11-19","current":-5.395061,"twenty":-11.075267,"median":-7.103477,"eighty":-4.700877,"marketCap":297505239},{"date":"2021-11-26","current":-5.447215,"twenty":-11.050991,"median":-7.080774,"eighty":-4.730547,"marketCap":300381230},{"date":"2021-12-03","current":-5.679011,"twenty":-11.002438,"median":-7.037757,"eighty":-4.748799,"marketCap":313163410},{"date":"2021-12-10","current":-9.859615,"twenty":-10.830768,"median":-7.080774,"eighty":-4.755552,"marketCap":543698631},{"date":"2021-12-17","current":-11.250893,"twenty":-10.84203,"median":-7.117764,"eighty":-4.75783,"marketCap":620419244},{"date":"2021-12-23","current":-11.300581,"twenty":-11.061395,"median":-7.134172,"eighty":-4.762613,"marketCap":623159266},{"date":"2021-12-31","current":-12.415023,"twenty":-11.108913,"median":-7.166339,"eighty":-4.768078,"marketCap":684614043},{"date":"2022-01-07","current":-11.016647,"twenty":-11.165437,"median":-7.180626,"eighty":-4.774685,"marketCap":607501998},{"date":"2022-01-14","current":-10.335205,"twenty":-11.153299,"median":-7.21974,"eighty":-4.806397,"marketCap":569924555},{"date":"2022-01-21","current":-8.468338,"twenty":-11.13249,"median":-7.234917,"eighty":-4.82753,"marketCap":466978018},{"date":"2022-01-28","current":-8.297977,"twenty":-11.116024,"median":-7.258799,"eighty":-4.833475,"marketCap":457583657},{"date":"2022-02-04","current":-8.951026,"twenty":-11.080469,"median":-7.300747,"eighty":-4.869457,"marketCap":493595373},{"date":"2022-02-11","current":-11.094729,"twenty":-11.080469,"median":-7.350163,"eighty":-4.875092,"marketCap":611807747},{"date":"2022-02-18","current":-9.66796,"twenty":-11.071799,"median":-7.413707,"eighty":-4.897933,"marketCap":533129975},{"date":"2022-02-25","current":-9.75314,"twenty":-11.030182,"median":-7.448213,"eighty":-4.938939,"marketCap":537827155},{"date":"2022-03-04","current":-8.915534,"twenty":-11.017273,"median":-7.472996,"eighty":-4.958303,"marketCap":491638215},{"date":"2022-03-11","current":-9.305944,"twenty":-11.010969,"median":-7.528178,"eighty":-4.97425,"marketCap":513166958},{"date":"2022-03-18","current":-10.355352,"twenty":-11.009549,"median":-7.586376,"eighty":-4.990731,"marketCap":642021454},{"date":"2022-03-25","current":-11.06286,"twenty":-11.009549,"median":-7.625279,"eighty":-5.041559,"marketCap":685886274},{"date":"2022-04-01","current":-13.384775,"twenty":-11.028394,"median":-7.660668,"eighty":-5.170516,"marketCap":829842638},{"date":"2022-04-08","current":-11.731777,"twenty":-11.098988,"median":-7.699533,"eighty":-5.231677,"marketCap":727358468},{"date":"2022-04-14","current":-10.876335,"twenty":-11.12261,"median":-7.716668,"eighty":-5.249902,"marketCap":674321913},{"date":"2022-04-22","current":-8.988146,"twenty":-11.103247,"median":-7.732957,"eighty":-5.26357,"marketCap":557256054},{"date":"2022-04-29","current":-9.510787,"twenty":-11.086173,"median":-7.802346,"eighty":-5.278378,"marketCap":589659313},{"date":"2022-05-06","current":-9.678549,"twenty":-11.077622,"median":-7.829679,"eighty":-5.295464,"marketCap":600060360},{"date":"2022-05-13","current":-13.123275,"twenty":-11.086173,"median":-7.836617,"eighty":-5.305715,"marketCap":473251543},{"date":"2022-05-20","current":-11.769903,"twenty":-11.161969,"median":-7.861263,"eighty":-5.31851,"marketCap":424446227},{"date":"2022-05-27","current":-13.034529,"twenty":-11.242695,"median":-7.869258,"eighty":-5.340635,"marketCap":470051194},{"date":"2022-06-03","current":-12.757199,"twenty":-11.285085,"median":-7.960694,"eighty":-5.368451,"marketCap":460050105},{"date":"2022-06-10","current":-13.234207,"twenty":-11.327253,"median":-7.981029,"eighty":-5.399697,"marketCap":477251979},{"date":"2022-06-17","current":-13.00125,"twenty":-11.375618,"median":-8.012128,"eighty":-5.411287,"marketCap":468851064},{"date":"2022-06-24","current":-15.120054,"twenty":-11.422222,"median":-8.034987,"eighty":-5.419003,"marketCap":545259385},{"date":"2022-07-01","current":-16.284842,"twenty":-11.553978,"median":-8.091112,"eighty":-5.423608,"marketCap":587263960},{"date":"2022-07-08","current":-20.633383,"twenty":-11.719384,"median":-8.168751,"eighty":-5.42983,"marketCap":744081040},{"date":"2022-07-15","current":-20.178561,"twenty":-11.769903,"median":-8.184404,"eighty":-5.44142,"marketCap":727679253},{"date":"2022-07-22","current":-18.913934,"twenty":-11.969581,"median":-8.226432,"eighty":-5.44142,"marketCap":682074286},{"date":"2022-07-29","current":-18.736442,"twenty":-12.060106,"median":-8.275008,"eighty":-5.447215,"marketCap":675673589},{"date":"2022-08-05","current":-20.788688,"twenty":-12.223294,"median":-8.303636,"eighty":-5.46367,"marketCap":749681650},{"date":"2022-08-12","current":-13.750684,"twenty":-12.362103,"median":-8.343585,"eighty":-5.46367,"marketCap":656540161},{"date":"2022-08-19","current":-12.768492,"twenty":-12.509551,"median":-8.420735,"eighty":-5.499341,"marketCap":609644435},{"date":"2022-08-26","current":-12.813137,"twenty":-12.536338,"median":-8.482534,"eighty":-5.510959,"marketCap":611776059},{"date":"2022-09-02","current":-12.777421,"twenty":-12.592247,"median":-8.603556,"eighty":-5.516754,"marketCap":610070760},{"date":"2022-09-09","current":-14.634657,"twenty":-12.609234,"median":-8.645174,"eighty":-5.544569,"marketCap":698746314},{"date":"2022-09-16","current":-14.072129,"twenty":-12.704679,"median":-8.738075,"eighty":-5.600145,"marketCap":671887853},{"date":"2022-09-23","current":-12.411332,"twenty":-12.737344,"median":-8.830852,"eighty":-5.64249,"marketCap":592591444},{"date":"2022-09-30","current":-12.69706,"twenty":-12.737344,"median":-8.887141,"eighty":-5.673216,"marketCap":606233837},{"date":"2022-10-07","current":-13.304233,"twenty":-12.761349,"median":-8.922632,"eighty":-5.692229,"marketCap":635223922},{"date":"2022-10-14","current":-14.831095,"twenty":-12.793892,"median":-8.951026,"eighty":-5.705496,"marketCap":708125459},{"date":"2022-10-21","current":-15.473984,"twenty":-12.959137,"median":-8.99443,"eighty":-5.755099,"marketCap":738820843},{"date":"2022-10-28","current":-15.348978,"twenty":-13.011811,"median":-9.007813,"eighty":-5.766877,"marketCap":732852296},{"date":"2022-11-04","current":-15.956151,"twenty":-13.109866,"median":-9.211253,"eighty":-5.781146,"marketCap":761842381},{"date":"2022-11-11","current":-16.355298,"twenty":-13.154285,"median":-9.27755,"eighty":-5.806364,"marketCap":911448044},{"date":"2022-11-18","current":-13.51023,"twenty":-13.225939,"median":-9.316592,"eighty":-5.88173,"marketCap":752898078},{"date":"2022-11-25","current":-13.187276,"twenty":-13.261571,"median":-9.354812,"eighty":-5.901857,"marketCap":734900515},{"date":"2022-12-02","current":-14.809734,"twenty":-13.320734,"median":-9.452716,"eighty":-5.911914,"marketCap":825316846},{"date":"2022-12-09","current":-13.279548,"twenty":-13.423882,"median":-9.515167,"eighty":-5.934118,"marketCap":740042676},{"date":"2022-12-16","current":-7.228011,"twenty":-13.398989,"median":-9.452716,"eighty":-5.976733,"marketCap":402802614},{"date":"2022-12-23","current":-6.097673,"twenty":-13.354338,"median":-9.354812,"eighty":-6.009039,"marketCap":339811142},{"date":"2022-12-30","current":-6.8743,"twenty":-13.325172,"median":-9.316592,"eighty":-6.00527,"marketCap":383090997},{"date":"2023-01-06","current":-6.443695,"twenty":-13.310335,"median":-9.281099,"eighty":-6.018456,"marketCap":359094245},{"date":"2023-01-13","current":-6.682066,"twenty":-13.30391,"median":-9.220763,"eighty":-5.960806,"marketCap":372378161},{"date":"2023-01-20","current":-6.797406,"twenty":-13.302617,"median":-9.171075,"eighty":-5.997732,"marketCap":378805863},{"date":"2023-01-27","current":-6.889679,"twenty":-13.279548,"median":-9.004264,"eighty":-6.016577,"marketCap":383948024},{"date":"2023-02-03","current":-6.735891,"twenty":-13.234207,"median":-8.958124,"eighty":-6.02597,"marketCap":375377755},{"date":"2023-02-10","current":-6.236082,"twenty":-13.225723,"median":-8.933129,"eighty":-6.037393,"marketCap":347524383},{"date":"2023-02-17","current":-6.489831,"twenty":-13.223872,"median":-8.915534,"eighty":-6.037393,"marketCap":361665326},{"date":"2023-02-24","current":-5.89006,"twenty":-13.194595,"median":-8.860478,"eighty":-6.03412,"marketCap":328241279},{"date":"2023-03-03","current":-5.982333,"twenty":-13.171574,"median":-8.80263,"eighty":-6.012808,"marketCap":333383440},{"date":"2023-03-10","current":-5.490213,"twenty":-13.16286,"median":-8.723879,"eighty":-5.944964,"marketCap":305958581},{"date":"2023-03-17","current":-4.573083,"twenty":-13.154285,"median":-8.610305,"eighty":-5.932447,"marketCap":319155464},{"date":"2023-03-24","current":-3.62523,"twenty":-13.129108,"median":-8.483849,"eighty":-5.897386,"marketCap":253004802},{"date":"2023-03-31","current":-3.545216,"twenty":-13.118034,"median":-8.454537,"eighty":-5.866992,"marketCap":247420656},{"date":"2023-04-06","current":-3.37288,"twenty":-13.113999,"median":-8.398808,"eighty":-5.809257,"marketCap":235393263},{"date":"2023-04-14","current":-3.557526,"twenty":-13.110445,"median":-8.342168,"eighty":-5.748484,"marketCap":248279755},{"date":"2023-04-21","current":-3.723921,"twenty":-13.086876,"median":-8.297405,"eighty":-5.667421,"marketCap":259892457},{"date":"2023-04-28","current":-3.55773,"twenty":-13.049491,"median":-8.275008,"eighty":-5.514436,"marketCap":248293951},{"date":"2023-05-05","current":-3.927044,"twenty":-13.024915,"median":-8.226432,"eighty":-5.46367,"marketCap":274068409},{"date":"2023-05-12","current":-2.71725,"twenty":-13.015752,"median":-8.184404,"eighty":-5.436784,"marketCap":286096490},{"date":"2023-05-19","current":-2.63566,"twenty":-13.012337,"median":-8.176277,"eighty":-5.402015,"marketCap":277506005},{"date":"2023-05-26","current":-2.256223,"twenty":-13.01026,"median":-8.097409,"eighty":-5.305715,"marketCap":237555450},{"date":"2023-06-02","current":-2.119544,"twenty":-13.006246,"median":-8.052131,"eighty":-5.261292,"marketCap":223164659},{"date":"2023-06-09","current":-2.313342,"twenty":-12.997558,"median":-8.029272,"eighty":-5.082716,"marketCap":243569512},{"date":"2023-06-16","current":-1.848226,"twenty":-12.976876,"median":-8.004338,"eighty":-4.951469,"marketCap":194597864},{"date":"2023-06-23","current":-1.782946,"twenty":-12.959137,"median":-7.983554,"eighty":-4.873965,"marketCap":187724650},{"date":"2023-06-30","current":-0.942473,"twenty":-12.911961,"median":-7.972124,"eighty":-4.816964,"marketCap":99232023},{"date":"2023-07-07","current":-1.28111,"twenty":-12.868469,"median":-7.949265,"eighty":-4.763979,"marketCap":134886820},{"date":"2023-07-14","current":-1.31783,"twenty":-12.843199,"median":-7.863618,"eighty":-4.74542,"marketCap":138753002},{"date":"2023-07-21","current":-1.207671,"twenty":-12.830007,"median":-7.840684,"eighty":-4.656454,"marketCap":127154454},{"date":"2023-07-28","current":-1.019992,"twenty":-12.803515,"median":-7.829679,"eighty":-4.602918,"marketCap":107393965},{"date":"2023-08-04","current":-0.966953,"twenty":-12.784417,"median":-7.802346,"eighty":-4.569798,"marketCap":101809478},{"date":"2023-08-11","current":-0.878871,"twenty":-12.773849,"median":-7.732957,"eighty":-4.533436,"marketCap":101205471},{"date":"2023-08-18","current":-0.736755,"twenty":-12.768492,"median":-7.716668,"eighty":-4.477622,"marketCap":84840331},{"date":"2023-08-25","current":-0.654478,"twenty":-12.76492,"median":-7.684387,"eighty":-4.455547,"marketCap":75365776},{"date":"2023-09-01","current":-0.747975,"twenty":-12.758617,"median":-7.652096,"eighty":-4.400662,"marketCap":86132316},{"date":"2023-09-08","current":-0.665698,"twenty":-12.756521,"median":-7.629237,"eighty":-4.34242,"marketCap":76657761},{"date":"2023-09-15","current":-0.669438,"twenty":-12.75227,"median":-7.594948,"eighty":-4.312673,"marketCap":77088422},{"date":"2023-09-22","current":-0.572201,"twenty":-12.743915,"median":-7.566374,"eighty":-4.236574,"marketCap":65891221},{"date":"2023-09-29","current":-0.531062,"twenty":-12.727534,"median":-7.484426,"eighty":-4.198554,"marketCap":61153944},{"date":"2023-10-06","current":-0.493664,"twenty":-12.69706,"median":-7.452079,"eighty":-4.156908,"marketCap":56847328},{"date":"2023-10-13","current":-0.504883,"twenty":-12.691703,"median":-7.415748,"eighty":-4.13135,"marketCap":58139313},{"date":"2023-10-20","current":-0.546022,"twenty":-12.664916,"median":-7.354927,"eighty":-4.067563,"marketCap":62876590},{"date":"2023-10-27","current":-0.478704,"twenty":-12.654201,"median":-7.3454,"eighty":-4.043715,"marketCap":55124682},{"date":"2023-11-03","current":-0.553502,"twenty":-12.626447,"median":-7.297775,"eighty":-4.002637,"marketCap":63737913},{"date":"2023-11-10","current":-0.376337,"twenty":-12.610697,"median":-7.240632,"eighty":-3.935494,"marketCap":53832697},{"date":"2023-11-17","current":-0.353056,"twenty":-12.606959,"median":-7.23304,"eighty":-3.832918,"marketCap":50502490},{"date":"2023-11-24","current":-0.359091,"twenty":-12.604608,"median":-7.223876,"eighty":-3.775539,"marketCap":51365781},{"date":"2023-12-01","current":-0.356073,"twenty":-12.598035,"median":-7.183484,"eighty":-3.742387,"marketCap":50934135},{"date":"2023-12-08","current":-0.413407,"twenty":-12.591669,"median":-7.172054,"eighty":-3.680708,"marketCap":59135395},{"date":"2023-12-15","current":-0.497899,"twenty":-12.589369,"median":-7.134281,"eighty":-3.606889,"marketCap":71221461},{"date":"2023-12-22","current":-0.4466,"twenty":-12.584725,"median":-7.117764,"eighty":-3.56011,"marketCap":63883492},{"date":"2023-12-29","current":-0.525057,"twenty":-12.580983,"median":-7.097292,"eighty":-3.545216,"marketCap":75106268},{"date":"2024-01-05","current":-0.651795,"twenty":-12.554196,"median":-7.08698,"eighty":-3.493515,"marketCap":93235367},{"date":"2024-01-12","current":-0.917341,"twenty":-12.52908,"median":-7.069188,"eighty":-3.412271,"marketCap":131220146},{"date":"2024-01-19","current":-0.737796,"twenty":-12.524241,"median":-7.035777,"eighty":-3.263323,"marketCap":105537256},{"date":"2024-01-26","current":-1.324851,"twenty":-12.51857,"median":-7.023513,"eighty":-2.747451,"marketCap":189511962},{"date":"2024-02-02","current":-1.772434,"twenty":-12.509859,"median":-7.000611,"eighty":-2.585064,"marketCap":253536017},{"date":"2024-02-09","current":-1.938779,"twenty":-12.491736,"median":-6.991314,"eighty":-2.31987,"marketCap":277330659},{"date":"2024-02-16","current":-1.720809,"twenty":-12.462618,"median":-6.972037,"eighty":-2.243983,"marketCap":246151473},{"date":"2024-02-23","current":-1.399592,"twenty":-12.450225,"median":-6.949178,"eighty":-2.172992,"marketCap":200203198},{"date":"2024-03-01","current":-1.347967,"twenty":-12.414285,"median":-6.907999,"eighty":-1.977153,"marketCap":192818653},{"date":"2024-03-08","current":-1.370912,"twenty":-12.401486,"median":-6.8743,"eighty":-1.880799,"marketCap":196100673},{"date":"2024-03-15","current":-1.175886,"twenty":-12.358945,"median":-6.850352,"eighty":-1.832088,"marketCap":168203506},{"date":"2024-03-22","current":-1.174797,"twenty":-12.339673,"median":-6.835853,"eighty":-1.784285,"marketCap":167594127},{"date":"2024-03-28","current":-1.341802,"twenty":-12.313113,"median":-6.812023,"eighty":-1.720809,"marketCap":191418782},{"date":"2024-04-05","current":-1.313008,"twenty":-12.311632,"median":-6.801251,"eighty":-1.686393,"marketCap":187311083},{"date":"2024-04-12","current":-1.289973,"twenty":-12.302962,"median":-6.791354,"eighty":-1.588881,"marketCap":184024924},{"date":"2024-04-19","current":-1.16638,"twenty":-12.277396,"median":-6.697444,"eighty":-1.399592,"marketCap":166393446},{"date":"2024-04-26","current":-1.042542,"twenty":-12.223294,"median":-6.665694,"eighty":-1.382114,"marketCap":148726981},{"date":"2024-05-03","current":-0.812146,"twenty":-12.21417,"median":-6.589793,"eighty":-1.370912,"marketCap":115859140},{"date":"2024-05-10","current":-0.938864,"twenty":-12.197035,"median":-6.535968,"eighty":-1.357033,"marketCap":133936452},{"date":"2024-05-17","current":-0.922882,"twenty":-12.194874,"median":-6.505876,"eighty":-1.341802,"marketCap":129012399},{"date":"2024-05-24","current":-0.899369,"twenty":-12.179177,"median":-6.443695,"eighty":-1.324851,"marketCap":125725459},{"date":"2024-05-31","current":-0.869978,"twenty":-12.088212,"median":-6.437221,"eighty":-1.31375,"marketCap":121616784},{"date":"2024-06-07","current":-0.822952,"twenty":-12.061179,"median":-6.407834,"eighty":-1.306296,"marketCap":115042904},{"date":"2024-06-14","current":-0.852343,"twenty":-12.055847,"median":-6.386025,"eighty":-1.290353,"marketCap":119151579},{"date":"2024-06-21","current":-0.799439,"twenty":-12.037385,"median":-6.32468,"eighty":-1.28809,"marketCap":111755964},{"date":"2024-06-28","current":-0.787682,"twenty":-12.021764,"median":-6.317751,"eighty":-1.28111,"marketCap":110112494},{"date":"2024-07-05","current":-0.640727,"twenty":-12.000582,"median":-6.289626,"eighty":-1.264729,"marketCap":89569118},{"date":"2024-07-12","current":-0.740657,"twenty":-11.985072,"median":-6.236551,"eighty":-1.250908,"marketCap":103538613},{"date":"2024-07-15","current":-0.711265,"twenty":-11.982873,"median":-6.236317,"eighty":-1.24294,"marketCap":99429938},{"date":"2024-08-02","current":-0.887612,"twenty":-11.980674,"median":-6.236082,"eighty":-1.238143,"marketCap":124081989},{"date":"2024-08-09","current":-0.781804,"twenty":-11.969581,"median":-6.205324,"eighty":-1.199511,"marketCap":109290758},{"date":"2024-08-16","current":-0.858275,"twenty":-11.817433,"median":-6.189946,"eighty":-1.16638,"marketCap":117833372},{"date":"2024-08-23","current":-0.924296,"twenty":-11.792089,"median":-6.174413,"eighty":-1.118526,"marketCap":126897478},{"date":"2024-08-30","current":-0.888284,"twenty":-11.791422,"median":-6.123071,"eighty":-1.079982,"marketCap":121953420},{"date":"2024-09-06","current":-0.864276,"twenty":-11.774207,"median":-6.117646,"eighty":-1.042246,"marketCap":118657382},{"date":"2024-09-13","current":-0.918294,"twenty":-11.746525,"median":-6.097673,"eighty":-1.023256,"marketCap":126073468},{"date":"2024-09-20","current":-0.912292,"twenty":-11.737434,"median":-6.059226,"eighty":-1.003173,"marketCap":125249459},{"date":"2024-09-27","current":-0.840269,"twenty":-11.732746,"median":-6.031064,"eighty":-0.967521,"marketCap":115361344},{"date":"2024-10-04","current":-0.852273,"twenty":-11.721863,"median":-5.997732,"eighty":-0.951895,"marketCap":117009363},{"date":"2024-10-11","current":-0.840269,"twenty":-11.652742,"median":-5.948405,"eighty":-0.941944,"marketCap":115361344},{"date":"2024-10-18","current":-0.888284,"twenty":-11.621631,"median":-5.943886,"eighty":-0.924013,"marketCap":121953420},{"date":"2024-10-25","current":-0.852273,"twenty":-11.588658,"median":-5.911442,"eighty":-0.918294,"marketCap":117009363},{"date":"2024-10-31","current":-0.816261,"twenty":-11.499297,"median":-5.901417,"eighty":-0.916531,"marketCap":112065305},{"date":"2024-11-08","current":-0.92967,"twenty":-11.439414,"median":-5.89006,"eighty":-0.912292,"marketCap":109593276},{"date":"2024-11-15","current":-0.73395,"twenty":-11.435946,"median":-5.866992,"eighty":-0.903278,"marketCap":86521008},{"date":"2024-11-22","current":-0.638886,"twenty":-11.429986,"median":-5.811777,"eighty":-0.89627,"marketCap":75314477},{"date":"2024-11-29","current":-0.78987,"twenty":-11.418431,"median":-5.784713,"eighty":-0.894286,"marketCap":93113084},{"date":"2024-12-06","current":-0.690193,"twenty":-11.401272,"median":-5.743886,"eighty":-0.888284,"marketCap":81362707},{"date":"2024-12-13","current":-0.681106,"twenty":-11.388213,"median":-5.695534,"eighty":-0.884414,"marketCap":80291495},{"date":"2024-12-20","current":-0.60135,"twenty":-11.375618,"median":-5.631169,"eighty":-0.87628,"marketCap":70889545},{"date":"2024-12-27","current":-0.67104,"twenty":-11.366584,"median":-5.534139,"eighty":-0.875575,"marketCap":79104921},{"date":"2025-01-03","current":-0.680687,"twenty":-11.366584,"median":-5.50515,"eighty":-0.869978,"marketCap":80242054},{"date":"2025-01-10","current":-0.67104,"twenty":-11.36489,"median":-5.476941,"eighty":-0.863653,"marketCap":79104921},{"date":"2025-01-17","current":-0.642801,"twenty":-11.345353,"median":-5.447215,"eighty":-0.858275,"marketCap":75775922},{"date":"2025-01-24","current":-0.659437,"twenty":-11.320593,"median":-5.44142,"eighty":-0.858275,"marketCap":77737065},{"date":"2025-01-31","current":-0.62211,"twenty":-11.303257,"median":-5.420147,"eighty":-0.852343,"marketCap":73336854},{"date":"2025-02-07","current":-0.71997,"twenty":-11.293364,"median":-5.395061,"eighty":-0.852273,"marketCap":84872988},{"date":"2025-02-14","current":-0.628751,"twenty":-11.288553,"median":-5.316757,"eighty":-0.84661,"marketCap":74119663},{"date":"2025-02-21","current":-0.699,"twenty":-11.285085,"median":-5.293755,"eighty":-0.846349,"marketCap":82400960},{"date":"2025-02-28","current":-0.600861,"twenty":-11.276415,"median":-5.256736,"eighty":-0.840269,"marketCap":70831865},{"date":"2025-03-07","current":-0.591354,"twenty":-11.263085,"median":-5.126616,"eighty":-0.836632,"marketCap":69711212},{"date":"2025-03-14","current":-0.54777,"twenty":-11.245427,"median":-4.977667,"eighty":-0.828729,"marketCap":64155873},{"date":"2025-03-21","current":-0.53958,"twenty":-11.234373,"median":-4.923562,"eighty":-0.822952,"marketCap":63196718},{"date":"2025-03-28","current":-0.600083,"twenty":-11.229199,"median":-4.869457,"eighty":-0.813792,"marketCap":70282887},{"date":"2025-04-04","current":-0.473712,"twenty":-11.203586,"median":-4.814322,"eighty":-0.799439,"marketCap":55482138},{"date":"2025-04-11","current":-0.315643,"twenty":-11.163703,"median":-4.768078,"eighty":-0.793561,"marketCap":36968798},{"date":"2025-04-17","current":-0.403326,"twenty":-11.153299,"median":-4.755552,"eighty":-0.78812,"marketCap":47238368},{"date":"2025-04-25","current":-0.433613,"twenty":-11.129197,"median":-4.74542,"eighty":-0.786538,"marketCap":50785587},{"date":"2025-05-02","current":-0.443708,"twenty":-11.111765,"median":-4.72138,"eighty":-0.781804,"marketCap":51967993},{"date":"2025-05-09","current":-0.337171,"twenty":-11.091877,"median":-4.642313,"eighty":-0.776791,"marketCap":39556862},{"date":"2025-05-16","current":-0.449785,"twenty":-11.07952,"median":-4.61317,"eighty":-0.765116,"marketCap":52768740},{"date":"2025-05-23","current":-0.506678,"twenty":-11.074939,"median":-4.578998,"eighty":-0.748428,"marketCap":59443407},{"date":"2025-05-30","current":-0.507594,"twenty":-11.071799,"median":-4.570346,"eighty":-0.742322,"marketCap":59550930},{"date":"2025-06-06","current":-0.528391,"twenty":-11.06286,"median":-4.539131,"eighty":-0.740495,"marketCap":61990863},{"date":"2025-06-13","current":-0.549823,"twenty":-11.019778,"median":-4.516989,"eighty":-0.73395,"marketCap":64505236},{"date":"2025-06-18","current":-0.473966,"twenty":-11.017899,"median":-4.500542,"eighty":-0.726139,"marketCap":55605680}],"updateTime":1750417039465}}}